Clinical trial
Venous Thromboembolic Prophylaxis After Major Trauma: A Randomized Controlled Trial of Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin
NCT01729559 is registered in ClinicalTrials.gov with Scripps Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Venous Thromboembolic Prophylaxis After Major Trauma: A Randomized Controlled Trial of Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin
- Lead sponsor
- Scripps Health
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2012
- Completion date
- October 31, 2014
- Enrollment
- 495 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
deep vein thrombosis, pulmonary embolism, venous thromboembolic disease